Global BioresorbableVascular Scaffold Market, by Product Type (Synthetic and Biological), byMaterial (Metal based BVS, Polymer based BVS), by Application (Coronary ArteryStents, Peripheral Artery Stents, and Others), by End User (Hospitals,Ambulatory Surgical Centers, Cardiac Centers, and Others), and by Region (NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa) wasvalued at US$ 147.0 million in 2017, and is projected to exhibit a CAGR of12.5% over the forecast period (2018 – 2026).
Launch of novel bioresorbablevascular scaffold by market players is expected to augment the market growthKey players in the market are focused on launching novel bioresorbable vascularscaffold in order to reduce the risk of coronary artery inflammation, whichleads to thrombosis and stent restenosis and address critical unmet needs ofpatients. For instance, in May 2017, Medtronic launched 4.5 mm and 5 mm sizesResolute Onyx, drug-eluting stent, in U.S. following FDA approval, which wasthe first drug-eluting stent. Similarly, in September 2012, Abbott launchedAbsorb, a bioresorbable vascular scaffold disappearing stent, across Europe andparts of Asia Pacific and Latin America. In May 2017 Medtronic, Plc. receivedU.S. Food and Drug Administration (FDA) approval for its Resolute Onyx, a 2.0mmsize zotarolimus-eluting stent with unique continuous sinusoid technology.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2471
Browse 22 Market Data Tables and26 Figures spread through 158 Pages and in-depth TOC on ‘Bioresorbable VascularScaffold Market’- Global Forecast to 2026, Product Type (Synthetic,Biological), by Material (Metal based BVS, Polymer Based BVS), by application(Coronary Artery Stents, Peripheral Artery Stents, Others), by End User(Hospitals, Ambulatory Surgical Centers, and Cardiac Centers, Others), and byRegion (North America, Latin America, Europe, Asia Pacific, Middle East, andAfrica)
Key players in the market arefocused on adopting strategies such as mergers and acquisitions to enhance itsproduct portfolio. For instance, in February 2016, Maquet Medical Systems, aGetinge Group Company, announced plans to enter into partnership withBIOTRONIK, a Germany-based manufacturer of cardiovascular and endovascularmedical devices, to distribute BIOTRONIK’s peripheral vascular devices in theU.S.
Key Takeaways of the BioresorbableVascular Scaffold Market:
The global bioresorbable vascularscaffold market is expected to exhibit a CAGR of 12.5% over the forecastperiod, owing to the increasing prevalence of cardiopulmonary conditions,cancer, and renal diseases
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/bioresorbable-vascular-scaffold-market-2471
Among product type, the syntheticsegment held a dominant position in the bioresorbable vascular scaffold marketin 2018, owing to higher adoption of synthetic bioresorbable vascular scaffoldover other treatment options such as antibiotic treatment and nutrition
Among material type, polymerbased segment held a dominant position in the bioresorbable vascular scaffoldmarket in 2018, due to its comparative advantages over metallic type.
Among application type, coronaryartery stents held a dominant position in the bioresorbable vascular scaffoldmarket in 2018, owing to high prevalence of cardiovascular diseases across theworld
Key players operating in theglobal bioresorbable vascular scaffold market include Abbott, Cook Medical,Boston Scientific Corporation, Stentys SA, MAQUET Holding B.V. & Co. KG(Getinge AB), W.L. Gore & Associates, Medtronic, C. R. Bard, Inc., B. BraunMelsungen AG, and Terumo Corporation among others
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2471
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offering action-readysyndicated research reports, custom market analysis, consulting services, andcompetitive analysis through various recommendations related to emerging markettrends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
